Biocon shares in focus on positive opinions for biosimilar Denosumab in Europe

Biocon Share Price | On April 23, Biocon board approved the raising of funds up to Rs 4,500 crore via the issuance of equity shares, non-convertible debt instruments along with warrants, by way of qualified institutions placement(s), rights issue, preferential allotment, or private placement(s), in one or more tranches..